GE HealthCare Technologies ($GEHC) Insider Trading & Smart Money Activity

GE HealthCare Technologies Inc. · Medical Devices · Latest filing Oct 12, 2026

GE HealthCare Technologies Inc. ($GEHC) has 1 congress trade, 7 13F position changes and 6 analyst ratings on file.

Insider buyers (12 mo)

0

Insider sellers (12 mo)

0

Net insider $ (12 mo)

$0

Congress trades (12 mo)

1

13F moves on file

7

Analyst ratings on file

6

GEHC insider buying and selling by quarter

Quarter	Insider buys	Insider sales	Congress buys / sales	13F added / cut
Q1 2026	0	0	1 / 0	0 / 0
Q2 2026	0	0	0 / 0	4 / 3
Q3 2026	0	0	0 / 0	0 / 0
Q4 2026	0	0	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All GEHC insider, congress, 13F and analyst activity

All Congress 13F Analysts

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	6M	Filing	Story
Oct 12, 2026	Analyst	BTIG	Reiterates to Buy		PT $75						Read
Oct 7, 2026	Analyst	Barclays	Reiterates to Overweight		PT $85		+5.9%				—
Oct 5, 2026	Analyst	Needham	Reiterates to Buy		PT $93		+3.0%				—
Sep 22, 2026	Analyst	Needham	Reiterates to Buy		PT $93		+0.3%				—
Sep 17, 2026	Analyst	BTIG	Reiterates to Buy		PT $79		+3.0%				—
Jun 23, 2026	Analyst	RBC Capital	Reiterates to buy		PT $80		+0.5%	-2.7%			Read
May 15, 2026	13F	Jacobs Levy Equity Management	Reduced	-46.01K sh	$82.42M		+5.7%	+6.6%			—
May 15, 2026	13F	Hotchkis & Wiley Capital Management	Added	+935.13K sh	$643.03M		+5.7%	+6.6%			—
May 15, 2026	13F	Hotchkis & Wiley Capital Management	Added	+935.13K sh	$638.04M		+5.7%	+6.6%			—
May 15, 2026	13F	Harris Associates L P	Reduced	-259.66K sh	$1.01B		+5.7%	+6.6%			—
May 15, 2026	13F	Harris Associates L P	Reduced	-259.66K sh	$998.24M		+5.7%	+6.6%			—
May 13, 2026	13F	Barrow Hanley Mewhinney & Strauss	Added	+5.38M sh	$766.67M		+3.8%	+5.3%			—
May 13, 2026	13F	Barrow Hanley Mewhinney & Strauss	Added	+5.38M sh	$760.73M		+3.8%	+5.3%			—
Mar 27, 2026	Congress	Alan Armstrong	Purchase		$1,001 - $15,000		+1.7%	+1.9%	-3.7%		—

1W / 1M / 6M = how GEHC moved from the trade or filing date.

Members of Congress trading GEHC

• Alan Armstrong1

Institutions moving GEHC (13F)

• Hotchkis & Wiley Capital Management2
• Harris Associates L P2
• Barrow Hanley Mewhinney & Strauss2
• Jacobs Levy Equity Management1

Analyst ratings on GEHC

Date	Firm	Action	Rating	Price target	1W	1M	6M	Story
Oct 12, 2026	BTIG	Reiterates	Buy	$79 → $75				Read
Oct 7, 2026	Barclays	Reiterates	Overweight	$85	+5.9%			—
Oct 5, 2026	Needham	Reiterates	Buy	$93	+3.0%			—
Sep 22, 2026	Needham	Reiterates	Buy	$93	+0.3%			—
Sep 17, 2026	BTIG	Reiterates	Buy	$79	+3.0%			—
Jun 23, 2026	RBC Capital	Reiterates	buy	$80	+0.5%	-2.7%		Read

Frequently asked questions

Which members of Congress traded GEHC?

1 disclosed trade by Alan Armstrong. The latest was on Mar 27, 2026.

Which institutions changed their GEHC positions?

Recent 13F filers moving the stock include Hotchkis & Wiley Capital Management, Harris Associates L P, Barrow Hanley Mewhinney & Strauss and Jacobs Levy Equity Management.

Other medical devices stocks

• $DXCM
• $STE
• $ZBH
• $TXG
• $BIO
• $GMED
• $PODD
• $GKOS

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.